tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tempus AI, Merck announce AI-driven precision medicine collaboration
PremiumThe FlyTempus AI, Merck announce AI-driven precision medicine collaboration
14d ago
Exelixis price target lowered to $43 from $46 at RBC Capital
Premium
The Fly
Exelixis price target lowered to $43 from $46 at RBC Capital
15d ago
Merck, Eisai announce results on Phase 3 Litespark-011 trial of Welireg
Premium
The Fly
Merck, Eisai announce results on Phase 3 Litespark-011 trial of Welireg
16d ago
Merck announces presentation of Phase 3 doravirine/islatravir results
PremiumThe FlyMerck announces presentation of Phase 3 doravirine/islatravir results
20d ago
Merck initiated with an Outperform at RBC Capital
Premium
The Fly
Merck initiated with an Outperform at RBC Capital
21d ago
Merck announces new operating structure in Human Health business
Premium
The Fly
Merck announces new operating structure in Human Health business
22d ago
FDA to begin requiring one clinical trial in drug approvals
PremiumThe FlyFDA to begin requiring one clinical trial in drug approvals
27d ago
Merck, Mayo Clinic announce new R&D collaboration
Premium
The Fly
Merck, Mayo Clinic announce new R&D collaboration
27d ago
Merck announces Health Canada approval of KEYTRUDA SC
Premium
The Fly
Merck announces Health Canada approval of KEYTRUDA SC
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100